Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.32%73.350.9%$628.11m
CELGCelgene Corporation
-0.08%131.261.1%$437.57m
AMGNAmgen Inc.
0.79%171.391.1%$428.25m
VRTXVertex Pharmaceuticals Incorporated
-0.88%151.371.9%$388.67m
BIIBBiogen Inc.
2.14%294.081.2%$369.29m
REGNRegeneron Pharmaceuticals, Inc.
-0.85%468.542.7%$323.23m
ALXNAlexion Pharmaceuticals, Inc.
0.99%136.551.9%$224.00m
ILMNIllumina, Inc.
0.12%194.153.5%$222.63m
SRPTSarepta Therapeutics, Inc.
1.96%37.4319.8%$145.52m
INCYIncyte Corporation
-1.61%124.342.6%$135.50m
CLVSClovis Oncology, Inc.
-0.15%71.7718.0%$123.60m
KITEKite Pharma, Inc.
1.02%128.0916.1%$116.66m
TSROTESARO, Inc.
-0.89%112.9914.7%$114.54m
BMRNBioMarin Pharmaceutical Inc.
-0.01%83.074.4%$113.75m
AAgilent Technologies, Inc.
4.67%62.151.5%$112.87m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.